Q&A: As RSV vaccine approvals loom, regulators need to devise vaccination strategies
Pharmaceutical Technology
MAY 1, 2023
After a long period of inactivity in RSV vaccine development , two pharmaceutical companies are now approaching regulatory decisions for their RSV vaccines. GAVI has created a market for the pharmaceutical companies to be able to develop enough doses for these LMIC markets.
52 
Let's personalize your content